Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | NVP-TAE684 | 0.031623 | uM | 4 | 625.00 | 368.38 | 606.00 | 582.00 | 1.0412 | 1.1263 |
| SK-BR-3 | 0 | uM | 4 | 625.00 | 368.38 | 529.00 | 582.00 | 0.9089 | 0.7306 | |
| SK-BR-3 | 0 | uM | 4 | 625.00 | 368.38 | 632.00 | 582.00 | 1.0859 | 1.2661 | |
| SK-BR-3 | 0 | uM | 4 | 625.00 | 368.38 | 461.00 | 582.00 | 0.7921 | 0.4048 | |
| SK-BR-3 | 0 | uM | 4 | 625.00 | 368.38 | 551.00 | 582.00 | 0.9467 | 0.8408 | |
| SK-BR-3 | PLX-4720 | 19.9526 | uM | 4 | 625.00 | 368.38 | 609.00 | 582.00 | 1.0464 | 1.1423 |
| SK-BR-3 | Nilotinib | 3.1623 | uM | 4 | 625.00 | 368.38 | 647.00 | 582.00 | 1.1117 | 1.3481 |
| SK-BR-3 | Etoposide | 0.0033113 | uM | 4 | 625.00 | 368.38 | 706.00 | 582.00 | 1.2131 | 1.6801 |
| SK-BR-3 | Etoposide | 0.031623 | uM | 4 | 625.00 | 368.38 | 720.00 | 582.00 | 1.2371 | 1.7611 |
| SK-BR-3 | PLX-4720 | 0.031623 | uM | 4 | 625.00 | 368.38 | 752.00 | 582.00 | 1.2921 | 1.9492 |
| SK-BR-3 | Nilotinib | 0.31623 | uM | 4 | 625.00 | 368.38 | 719.00 | 582.00 | 1.2354 | 1.7553 |
| SK-BR-3 | NVP-TAE684 | 0.0033113 | uM | 4 | 625.00 | 368.38 | 774.00 | 582.00 | 1.3299 | 2.0809 |
| SK-BR-3 | PLX-4720 | 0.1 | uM | 4 | 625.00 | 368.38 | 612.00 | 582.00 | 1.0515 | 1.1583 |
| SK-BR-3 | NVP-TAE684 | 0.1 | uM | 4 | 625.00 | 368.38 | 619.00 | 582.00 | 1.0636 | 1.1958 |
| SK-BR-3 | NVP-TAE684 | 0.01 | uM | 4 | 625.00 | 368.38 | 824.00 | 582.00 | 1.4158 | 2.3875 |
| SK-BR-3 | 0 | uM | 4 | 625.00 | 368.38 | 806.00 | 582.00 | 1.3849 | 2.2760 | |
| SK-BR-3 | Nilotinib | 0.01 | uM | 4 | 625.00 | 368.38 | 651.00 | 582.00 | 1.1186 | 1.3701 |
| SK-BR-3 | 0 | uM | 4 | 625.00 | 368.38 | 568.00 | 582.00 | 0.9760 | 0.9275 | |
| SK-BR-3 | NVP-TAE684 | 0.31623 | uM | 4 | 625.00 | 368.38 | 677.00 | 582.00 | 1.1632 | 1.5151 |
| SK-BR-3 | Etoposide | 0.01 | uM | 4 | 625.00 | 368.38 | 555.00 | 582.00 | 0.9536 | 0.8611 |
| SK-BR-3 | Etoposide | 1 | uM | 4 | 625.00 | 368.38 | 360.00 | 582.00 | 0.6186 | -0.0343 |
| SK-BR-3 | PLX-4720 | 10 | uM | 4 | 625.00 | 368.38 | 685.00 | 582.00 | 1.1770 | 1.5602 |
| SK-BR-3 | Etoposide | 10 | uM | 4 | 625.00 | 368.38 | 271.00 | 582.00 | 0.4656 | -0.3720 |
| SK-BR-3 | Nilotinib | 0.0033113 | uM | 4 | 625.00 | 368.38 | 551.00 | 582.00 | 0.9467 | 0.8408 |
| SK-BR-3 | PLX-4720 | 0.01 | uM | 4 | 625.00 | 368.38 | 588.00 | 582.00 | 1.0103 | 1.0313 |